Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients

NCT01884441 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Lymphoma

Interventions

DRUG: Bendamustine
DRUG: Gemcitabine
DRUG: Vinorelbine

Sponsor

Armando Santoro, MD